<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02733237</url>
  </required_header>
  <id_info>
    <org_study_id>UESTC-neuSCAN-04</org_study_id>
    <nct_id>NCT02733237</nct_id>
  </id_info>
  <brief_title>Oxytocin Effects on the Tolerance of Infidelity</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Electronic Science and Technology of China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Electronic Science and Technology of China</source>
  <brief_summary>
    <textblock>
      To investigate whether intranasal oxytocin (40 IU) treatment can influence the tolerance of
      infidelity in males and females.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a double-blind, between-subject, placebo controlled design, investigators plan to
      investigate the effect of oxytocin treatment on the tolerance of infidelity. Male and female
      subjects would firstly see a neutral face of the opposite sex presented with a sentence
      descried their fidelity or infidelity behavior (sexual or emotional) in a relationship. Next
      the participant will rate the attractiveness, likability and trustworthiness of each
      individual, and whether they would like to have a short/long relationship with him/her. After
      that there will be some implicit attitude tasks to test their implicit attitude towards
      potential partners exhibiting previous fidelity or and infidelity.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>attitude towards fidelity and infidelity of potential mate.</measure>
    <time_frame>1 hour</time_frame>
    <description>attitude is measured by the rating scores for likability, attractiveness and trustworthiness</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>male oxytocin group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>male subjects with oxytocin treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>female oxytocin group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>female subjects with oxytocin treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>male placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>male subjects with placebo treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>female placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>female subjects with placebo treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>oxytocin treatment</intervention_name>
    <description>intranasal administration of oxytocin (40 IU)</description>
    <arm_group_label>male oxytocin group</arm_group_label>
    <arm_group_label>female oxytocin group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo treatment</intervention_name>
    <description>intranasal administration of placebo (40 IU)</description>
    <arm_group_label>male placebo group</arm_group_label>
    <arm_group_label>female placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy subjects without past or current psychiatric or neurological disorders

        Exclusion Criteria:

          -  history of head injury;

          -  pregnant,menstruating,taking oral contraceptives

          -  medical or psychiatric illness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>28 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keith Kendrick, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Electronic Science and Technology of China</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>China, Sichuan</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>611731</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2016</study_first_submitted>
  <study_first_submitted_qc>April 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2016</study_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Electronic Science and Technology of China</investigator_affiliation>
    <investigator_full_name>Keith Kendrick</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>oxytocin</keyword>
  <keyword>infidelity</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

